Skip to content
value.today

Reciprocal Labs Corp

🇺🇸 Madison, Wisconsin, USAPharmaceuticalsFounded 2010
Total raised
$65 M
5 rounds on record
Latest round
$20 M
May 2018
First round on record
Jun 2012
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Reciprocal Labs Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2018$20 MNo. 5$10 to $50 million

Reciprocal Labs Corp: Raise no. 5, May 2018

Investors in this round

7 investors had bought by the notice of Jun 5, 2018: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $24 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Van Sickle · Executive Officer, Director
  • Greg Tracy · Executive Officer, Director
  • Gary Kurtzman · Director
  • Ted Maidenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Van Sickle, Ceo. Source: SEC Form D, newest notice filed Jun 5, 2018. Read the notice at the SEC.

equitySEC
Oct 2016$22 MNo. 4$10 to $50 million

Reciprocal Labs Corp: Raise no. 4, Oct 2016

Investors in this round

5 investors had bought by the notice of Oct 20, 2016: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Van Sickle · Executive Officer, Director
  • Greg Tracy · Executive Officer, Director
  • Gary Kurtzman · Director
  • Ted Maidenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “33,509,973 shares of Series C Preferred Stock at $0.6416 per share for $21,500,000 raise.”

Signed by David Van Sickle, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 20, 2016. Read the notice at the SEC.

equitySEC
Aug 2014$15 MNo. 3$10 to $50 million

Reciprocal Labs Corp: Raise no. 3, Aug 2014

Investors in this round

3 investors had bought by the notice of Sep 8, 2014: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
$1,000,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Hogg · Executive Officer
  • David Van Sickle · Executive Officer, Director
  • Erica St. Angel · Executive Officer
  • Greg Tracy · Executive Officer, Director
  • Gary Kurtzman · Director
  • Rob Monahan · Director
  • Ted Maidenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds are used for research and development and general corporate purposes. The executive officers will receive compensation from the Issuer's revenues and investment proceeds.”

Signed by David Van Sickle, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 8, 2014. Read the notice at the SEC.

equitySEC
Mar 2013$7 MNo. 2$2 to $10 million

Reciprocal Labs Corp: Raise no. 2, Mar 2013

Investors in this round

7 investors had bought by the notice of Apr 1, 2013: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$150,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Van Sickle · Executive Officer, Director
  • Mark Gehring · Executive Officer, Director
  • Jeffrey Rusinow · Director
  • Rob Monahan · Director
  • Ted Maidenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Van Sickle, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 1, 2013. Read the notice at the SEC.

equitySEC
Jun 2012$2 MNo. 1Under $2 million

Reciprocal Labs Corp: Raise no. 1, Jun 2012

Investors in this round

6 investors had bought by the notice of Jun 25, 2012: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Wisconsin

People named in the notice

  • David Van Sickle · Executive Officer, Director
  • Mark Gehring · Executive Officer, Director
  • Jeffrey Rusinow · Director
  • Rob Monahan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Van Sickle, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 25, 2012. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Reciprocal Labs Corp chose not to state its revenue in its newest notice of a funding round (Jun 2018).

    SEC Form D · Jun 2018

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jun 2018

That is all the official record says: Reciprocal Labs Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Reciprocal Labs Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Reciprocal Labs Corp
NameRoleNamed in
David Van SickleExecutive officerJun 2018
Greg TracyExecutive officerJun 2018
Chris HoggExecutive officerSep 2014
Erica St. AngelExecutive officerSep 2014
Mark GehringExecutive officerApr 2013
David Van SickleDirectorJun 2018
Gary KurtzmanDirectorJun 2018
Greg TracyDirectorJun 2018
Ted MaidenbergDirectorJun 2018
Rob MonahanDirectorSep 2014
Jeffrey RusinowDirectorApr 2013
Mark GehringDirectorApr 2013